483 SpecGx Nov 2016

483 SpecGx Nov 2016

Tiara Brown-Crosen FDA$119.00 - Available Now

FDA investigators audited the SpecGx - Saint Louis, MO, United States facility and issued inspectional observations (via FDA 483) on 22 Nov 2016.

Product details

  • Category: Human Drugs
  • Inspection end: 22 Nov 2016
  • Location: Saint Louis, United States
  • FEI: 1940521
Add To Cart